Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
ArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd. 2021-07-21 20:33
1